España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

pfizer s.l. - gemfibrozilo - comprimido recubierto con pelÍcula - 600 mg - gemfibrozilo 600 mg - gemfibrozilo

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

pfizer s.l. - gemfibrozilo - comprimido recubierto con pelÍcula - 900 mg - gemfibrozilo 900 mg - gemfibrozilo

Unión Europea - español - EMA (European Medicines Agency)

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - agentes antineoplásicos - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.